p21, encoded by the gene CDKN1A, is the founding member of cyclin-dependent kinase (Cdk) inhibitors (CKI) [1], a pivotal cell cycle regulator ensuring genomic stability and often deregulated in human cancer [2,3,4]. Here, CDKN1A is linked to cancer.